GLI1 and Familial prostate cancer: In addition, mTOR/S6K1 signaling has been shown to contribute to radiotherapy-induced GLI1 activity in head and neck squamous cell carcinoma cell lines [97] and to enhance GLI1 expression in prostate cancer cell lines [98].